Learn about the latest advances in head and neck cancer treatment through this 23-minute conference presentation from Yale's Review of Advances in Oncology covering key findings from the 2025 ASCO Annual Meeting. Explore cutting-edge research, clinical trial results, and emerging therapeutic approaches in head and neck oncology as presented by Dr. Barbara Burtness from Yale Cancer Center. Gain insights into current treatment paradigms, novel drug developments, immunotherapy applications, and precision medicine strategies specifically targeting head and neck malignancies. Discover how recent ASCO findings are shaping clinical practice and improving patient outcomes in this specialized area of oncology care.